About Obio Technology Company

The company was founded in 2013 and is a biotechnology company focusing on the field of gene therapy. It focuses on providing CRO services such as gene therapy vector development, gene function research, drug targets and pharmacodynamics research for basic gene therapy research, and CDMO services such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for genetic drug research. The company focuses on providing integrated CRO/CDMO services such as gene therapy vector construction, target and efficacy research, process development and testing, IND-CMC pharmaceutical research, clinical phase I-III, and commercial GMP production for leading gene therapy research and drug development such as recombinant virus vector products, oncolytic virus products, and CAR-T products. Main products: Plasmids, adeno-associated virus, lentivirus, etc.; various oncolytic virus products such as oncolytic herpes virus and oncolytic pox virus; cell therapy products such as CAR-T and CAR-NK; technical research, process development, and GMP production services for other products such as mRNA.